Zydus Cadila gets tentative approval from USFDA for Adapalene and Benzoyl Peroxide Gel
8th Oct 2021

Zydus Cadila has received tentative approval from the USFDA to market Adapalene and Benzoyl Peroxide Gel 0.3%/2.5%. (USRLD: Epiduo Forte). Adapalene and Benzoyl Peroxide combination is used to treat acne. It works by killing the bacteria that cause acne and by keeping the skin pores clean. The drug will be manufactured at the group’s Topical plant at Ahmedabad.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.